Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03682055 |
| Title | Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Cullinan Apollo Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Stanford University, School of Medicine, Stanford Cancer Institute | Stanford | California | 94305 | United States | Details | |
| The University of Texas - MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Sun Yat Sen University Cancer Center | Guangzhou | Guangdong | 510060 | China | Details | |
| Institut Gustave Roussy | Villejuif | 94800 | France | Details | ||
| Hong Kong University - Queen Mary Hospital | Hong Kong | Hong Kong | Details | |||
| National Cancer Centre Singapore | Singapore | 169610 | Singapore | Details |